This Common Antibiotic May Help Fight Cancer When Given Before Radiation

By Rob Dillard - Last Updated: June 30, 2023

Administering a dose of the common antibiotic vancomycin before radiation therapy may help immune cells kill tumors, according to a new study published in the Journal of Clinical Investigation.

Advertisement

In this study, researchers used a mouse-model to uncover that vancomycin enhances the function of dendritic cells, which are the messenger cells that relay to T cells what to attack. The researchers used melanoma, lung, and cervical cancer models for this work,  and noted the approach could have implications for a wide variety of cancer types. Moreover, the study also builds off the team’s previous research, which showed a similar effect in T cell therapies,

However, the researchers caution this study only scratches the surface when it comes to understanding the connection between the makeup of the gut microbiome and its impact on radiotherapy-induced immune responses to cancer. They say further research is needed to elucidate their findings.

“Our study shows that vancomycin seems to boost the effect of the hypo-fractionated radiation itself on the targeted tumor site while also aiding the abscopal effect, helping the immune system fight tumors away from the treatment site,” said the study’s senior author Andrea Facciabene, PhD, an associate professor of Radiation Oncology in Penn’s Perelman School of Medicine in a press release.

“However, what’s clear is that antibiotics play a role and can potentially impact treatments and outcomes for cancer patients,” Facciabene said. The researchers are planning a phase 1 study to translate this approach into the clinic.

 

Advertisement